首页 > 最新文献

Medicom Conference Report SABCS 2023最新文献

英文 中文
No radiotherapy after breast-conserving surgery is safe in selected younger patients 在选定的年轻患者中,保乳手术后不进行放疗是安全的
Pub Date : 2024-01-11 DOI: 10.55788/2748a906
Marten Dooper
{"title":"No radiotherapy after breast-conserving surgery is safe in selected younger patients","authors":"Marten Dooper","doi":"10.55788/2748a906","DOIUrl":"https://doi.org/10.55788/2748a906","url":null,"abstract":"","PeriodicalId":516760,"journal":{"name":"Medicom Conference Report SABCS 2023","volume":"45 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140510194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fast menstrual resumption after interruption of endocrine therapy 内分泌治疗中断后月经迅速恢复
Pub Date : 2024-01-11 DOI: 10.55788/2a521413
Marten Dooper
{"title":"Fast menstrual resumption after interruption of endocrine therapy","authors":"Marten Dooper","doi":"10.55788/2a521413","DOIUrl":"https://doi.org/10.55788/2a521413","url":null,"abstract":"","PeriodicalId":516760,"journal":{"name":"Medicom Conference Report SABCS 2023","volume":"53 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140510319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adjuvant ribociclib improves IDFS in early breast cancer 利福昔布辅助治疗可改善早期乳腺癌的 IDFS
Pub Date : 2024-01-11 DOI: 10.55788/c799e95f
Marten Dooper
{"title":"Adjuvant ribociclib improves IDFS in early breast cancer","authors":"Marten Dooper","doi":"10.55788/c799e95f","DOIUrl":"https://doi.org/10.55788/c799e95f","url":null,"abstract":"","PeriodicalId":516760,"journal":{"name":"Medicom Conference Report SABCS 2023","volume":"57 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140510301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OS benefit of adjuvant T-DM1 in early breast cancer with residual disease after neoadjuvant therapy T-DM1辅助治疗新辅助治疗后有残留病灶的早期乳腺癌的OS效益
Pub Date : 2024-01-11 DOI: 10.55788/48799caa
Marten Dooper
{"title":"OS benefit of adjuvant T-DM1 in early breast cancer with residual disease after neoadjuvant therapy","authors":"Marten Dooper","doi":"10.55788/48799caa","DOIUrl":"https://doi.org/10.55788/48799caa","url":null,"abstract":"","PeriodicalId":516760,"journal":{"name":"Medicom Conference Report SABCS 2023","volume":"13 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140509899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addition of inavolisib to palbociclib and fulvestrant reduces risk of progression 在palbociclib和氟维司群基础上加用inavolisib可降低病情恶化的风险
Pub Date : 2024-01-11 DOI: 10.55788/c467c2c1
Marten Dooper
{"title":"Addition of inavolisib to palbociclib and fulvestrant reduces risk of progression","authors":"Marten Dooper","doi":"10.55788/c467c2c1","DOIUrl":"https://doi.org/10.55788/c467c2c1","url":null,"abstract":"","PeriodicalId":516760,"journal":{"name":"Medicom Conference Report SABCS 2023","volume":"46 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140510328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bilateral mastectomy and breast-conserving surgery have equal impact on breast cancer-specific mortality in pathogenic BRCA1 carriers 双侧乳房切除术和保乳手术对致病性 BRCA1 携带者乳腺癌特异性死亡率的影响相同
Pub Date : 2024-01-11 DOI: 10.55788/2ecf6b07
Marten Dooper
{"title":"Bilateral mastectomy and breast-conserving surgery have equal impact on breast cancer-specific mortality in pathogenic BRCA1 carriers","authors":"Marten Dooper","doi":"10.55788/2ecf6b07","DOIUrl":"https://doi.org/10.55788/2ecf6b07","url":null,"abstract":"","PeriodicalId":516760,"journal":{"name":"Medicom Conference Report SABCS 2023","volume":"23 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140510626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atezolizumab improves pCR in HER2-positive early breast cancer 阿特珠单抗可改善 HER2 阳性早期乳腺癌的 pCR
Pub Date : 2024-01-11 DOI: 10.55788/36fd57da
Marten Dooper
{"title":"Atezolizumab improves pCR in HER2-positive early breast cancer","authors":"Marten Dooper","doi":"10.55788/36fd57da","DOIUrl":"https://doi.org/10.55788/36fd57da","url":null,"abstract":"","PeriodicalId":516760,"journal":{"name":"Medicom Conference Report SABCS 2023","volume":"29 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140510743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exercise programme improves quality of life for patients with metastatic breast cancer 运动计划提高转移性乳腺癌患者的生活质量
Pub Date : 2024-01-11 DOI: 10.55788/7a9db0d5
Marten Dooper
{"title":"Exercise programme improves quality of life for patients with metastatic breast cancer","authors":"Marten Dooper","doi":"10.55788/7a9db0d5","DOIUrl":"https://doi.org/10.55788/7a9db0d5","url":null,"abstract":"","PeriodicalId":516760,"journal":{"name":"Medicom Conference Report SABCS 2023","volume":"42 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140510413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
(More) axillary surgery does not influence long-term recurrence (更多)腋窝手术不会影响长期复发
Pub Date : 2024-01-11 DOI: 10.55788/cbccf707
Marten Dooper
{"title":"(More) axillary surgery does not influence long-term recurrence","authors":"Marten Dooper","doi":"10.55788/cbccf707","DOIUrl":"https://doi.org/10.55788/cbccf707","url":null,"abstract":"","PeriodicalId":516760,"journal":{"name":"Medicom Conference Report SABCS 2023","volume":"31 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140510285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Highest benefit of neoadjuvant nivolumab in breast tumours with high PD-L1 expression and/or low ER expression 在PD-L1高表达和/或ER低表达的乳腺肿瘤中,新辅助治疗nivolumab的收益最高
Pub Date : 2024-01-11 DOI: 10.55788/b2fd44f8
Marten Dooper
{"title":"Highest benefit of neoadjuvant nivolumab in breast tumours with high PD-L1 expression and/or low ER expression","authors":"Marten Dooper","doi":"10.55788/b2fd44f8","DOIUrl":"https://doi.org/10.55788/b2fd44f8","url":null,"abstract":"","PeriodicalId":516760,"journal":{"name":"Medicom Conference Report SABCS 2023","volume":"51 3-4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140510249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medicom Conference Report SABCS 2023
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1